open access

Vol 77, No 1 (2009)
Published online: 2008-12-19
Submitted: 2013-02-22
Get Citation

Early diagnosis of COPD - rationale, methods and effects

Jan Zieliński
Pneumonol Alergol Pol 2009;77(1):77-81.

open access

Vol 77, No 1 (2009)
Published online: 2008-12-19
Submitted: 2013-02-22

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Early diagnosis of COPD - rationale, methods and effects

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 1 (2009)

Pages

77-81

Published online

2008-12-19

Bibliographic record

Pneumonol Alergol Pol 2009;77(1):77-81.

Authors

Jan Zieliński

References (22)
  1. Sackett DL. Screening for early detection of disease: to what purpose? Bull N Y Acad Med. 1975; 51(1): 39–52.
  2. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest. 2000; 117(4): 1146–1161.
  3. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002; 166(5): 675–679.
  4. Walker PP, Mitchell P, Diamantea F, et al. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J. 2006; 28(5): 945–952.
  5. Mannino DM, Aguayo SM, Petty TL, et al. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med. 2003; 163(12): 1475–1480.
  6. Lindberg A, Bjerg A, Bjerg-Bäcklund A, et al. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006; 100(2): 264–272.
  7. Peña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000; 118(4): 981–989.
  8. Maciejewski J. Częstość występowania POChP w praktyce lekarza rodzinnego. Probl Med Rodz. 2008; 10: 7–14.
  9. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349(9064): 1498–1504.
  10. Anthonisen NR, Skeans MA, Wise RA, et al. Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005; 142(4): 233–239.
  11. Burrows B, Knudson RJ, Cline MG, et al. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis. 1977; 115(2): 195–205.
  12. Zieliński J, Bednarek M, Górecka D. w imieniu grupy „Poznaj Wiek Swoich Płuc”. Narodowy program wczesnego rozpoznawania i profilaktyki POChP w latach 2000–2002. Pneumonol Alergol Pol. 2005; 73: 116–121.
  13. Zielinski J. Increasing COPD awareness. European Respiratory Journal. 2006; 27(4): 833–852.
  14. Stratelis G, Jakobsson P, Molstad S, et al. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract. 2004; 54(500): 201–206.
  15. Van Schayck CP, Loozen JMC, Wagena E, et al. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ. 2002; 324(7350): 1370–1375.
  16. Buffels J, Degryse J, Heyrman J, et al. DIDASCO Study. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004; 125(4): 1394–1399.
  17. Vandevoorde J, Verbanck S, Gijssels L, et al. Early detection of COPD: a case finding study in general practice. Respir Med. 2007; 101(3): 525–530.
  18. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152(3): 1107–1136.
  19. Agency for Healthcare Research and Quality. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). AHRQ Publication No 05-E017-2. 2005.
  20. Lin K, Watkins B, Johnson T, et al. U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 148(7): 535–543.
  21. Petty TL, Mannino DM. Will recommendations against spirometry make chronic obstructive pulmonary disease harder to treat? Ann Intern Med. 2008; 149(7): 512.
  22. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J. 2007; 30(4): 616–622.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl